Skip to main content
Top

Current Hypertension Reports

Issue 7/2023

Content (3 Articles)

Hypertension Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)

Neurogenic Background for Emotional Stress-Associated Hypertension

Marco Antônio Peliky Fontes, Fernanda Ribeiro Marins, Tapan A. Patel, Cristiane Amorim de Paula, Liliane Ramos dos Santos Machado, Érick Bryan de Sousa Lima, Ana Caroline Ventris-Godoy, Ana Clara Rocha Viana, Isadora Cristina Souza Linhares, Carlos Henrique Xavier, Jessica A. Filosa, Kaushik P. Patel

Open Access Insulins Pediatric Hypertension (C Hanevold, Section Editor)

Effects of Puberty on Blood Pressure Trajectories — Underlying Processes

Małgorzata Wójcik, Jerzy B. Starzyk, Monika Drożdż, Dorota Drożdż

Open Access Hypertension Nutrition and Hypertension (T Mori, Section Editor)

Plant-Based Diets Reduce Blood Pressure: A Systematic Review of Recent Evidence

João Tomé-Carneiro, Francesco Visioli

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine